# Biomarin Pharmaceutical Inc: Form 8-K, filed Aug 28, 2024

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K
- Filed: 2024-08-28
- Accepted by EDGAR: Aug 28, 2024, 17:02 ET
- Period: 2024-08-23
- Accession: 0001048477-24-000132
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000104847724000132/bmrn-20240823.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000104847724000132/

## Items reported

- Item 2.05: Exit or disposal costs

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000104847724000132/bmrn-20240823.htm

Filed Aug 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001048477-24-000132. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.